×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
戻る Agenda
Poster Presentations and Networking Reception
Session Chair(s)
Session Chair Invited
Manager
DIA, United States
Poster Presentations and Networking Reception
Speaker(s)
Redaction Impact and Efficiencies Assessed for Optimal Transparency Preparation for the EU Clinical Trial Regulation 536/2014
Michelle Hellstern, BSN
CSL Behring, United States
Manager, Clinical Trial Disclosure & Transparency
Assessment of Anonymization Methods, Processes, and Challenges for Clinical Information Submissions to Health Canada
Raina Agarwal, MPharm
Kinapse Ltd, A Syneos Health Company, United States
Senior Manager
Do You Know Your Risk?
Cathal Gallagher
Regeneron, United Kingdom
Associate Director Clinical Transparency & Trial Disclosure
Experiences Generating Synthetic Clinical Trial Data
Lucy Mosquera, MSc
Replica Analytics, Canada
Senior Director, Data Science
Automating Data Anonymization Procedures with Software
Veera Thota
MMS Holdings, United States
Actionable Insights for Plain Language Summary Implementation
Pooja Phogat, PhD
Krystelis Ltd., India
Founder and Co-CEO
The Future of Transparency: How Global Regulatory Authorities May Expect Patient and HCP Engagement During the Drug Approval Process
Nirpal Virdee, MSc
Certara, United Kingdom
Head, Transparency & Disclosure